DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Joerger M, Cassier PA, Penel N. et al.
Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway.
Journal of Clinical Oncology 2018;
36: 4513
We do not assume any responsibility for the contents of the web pages of other providers.